I don't entirely agree that the share price will only fly with an international deal.
The share price is still ~10% under the EBOS placement.
There's so many ways in which MedAdvisor will be used within EBOS - Terry White Group, Zest, HPS, Symbion etc.
Look at the recent market fluctuations, some technology, small cap stocks are down 30% or more. This suggests the market trusts MDRs numbers, forecasts and partnerships.
The share price is where it is because of the register. A huge percentage of the shares on issue are held by Management, institutions and now a cornerstone investor (EBOS). If they didn't believe in the business model or trust the product roadmap then we would be back near listing price.
I've been here a long time and trust that patience will reward shareholders.
MDR Charting, page-292
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $220.5M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 41.5¢ | 40.0¢ | $43.65K | 108.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 46211 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 16830 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| MDR (ASX) Chart |